4l02

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
'''Unreleased structure'''
+
{{STRUCTURE_4l02| PDB=4l02 | SCENE= }}
 +
===Crystal Structure of SphK1 with inhibitor===
 +
{{ABSTRACT_PUBMED_23845219}}
-
The entry 4l02 is ON HOLD until Paper Publication
+
==Function==
 +
[[http://www.uniprot.org/uniprot/SPHK1_HUMAN SPHK1_HUMAN]] Catalyzes the phosphorylation of sphingosine to form sphingosine 1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions. Also acts on D-erythro-sphingosine and to a lesser extent sphinganine, but not other lipids, such as D,L-threo-dihydrosphingosine, N,N-dimethylsphingosine, diacylglycerol, ceramide, or phosphatidylinositol.<ref>PMID:20577214</ref>
-
Authors: Min, X., Walker, N., Wang, Z.
+
==About this Structure==
 +
[[4l02]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4L02 OCA].
-
Description: Crystal Structure of SphK1 with inhibitor
+
==Reference==
 +
<ref group="xtra">PMID:023845219</ref><references group="xtra"/><references/>
 +
[[Category: Homo sapiens]]
 +
[[Category: Sphinganine kinase]]
 +
[[Category: Min, X.]]
 +
[[Category: Walker, N.]]
 +
[[Category: Wang, Z.]]
 +
[[Category: Lipid kinase]]
 +
[[Category: Transferase-transferase inhibitor complex]]

Revision as of 12:59, 24 July 2013

Template:STRUCTURE 4l02

Contents

Crystal Structure of SphK1 with inhibitor

Template:ABSTRACT PUBMED 23845219

Function

[SPHK1_HUMAN] Catalyzes the phosphorylation of sphingosine to form sphingosine 1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions. Also acts on D-erythro-sphingosine and to a lesser extent sphinganine, but not other lipids, such as D,L-threo-dihydrosphingosine, N,N-dimethylsphingosine, diacylglycerol, ceramide, or phosphatidylinositol.[1]

About this Structure

4l02 is a 3 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

  • Gustin DJ, Li Y, Brown ML, Min X, Schmitt MJ, Wanska M, Wang X, Connors R, Johnstone S, Cardozo M, Cheng AC, Jeffries S, Franks B, Li S, Shen S, Wong M, Wesche H, Xu G, Carlson TJ, Plant M, Morgenstern K, Rex K, Schmitt J, Coxon A, Walker N, Kayser F, Wang Z. Structure guided design of a series of sphingosine kinase (SphK) inhibitors. Bioorg Med Chem Lett. 2013 Jun 20. pii: S0960-894X(13)00739-7. doi:, 10.1016/j.bmcl.2013.06.030. PMID:23845219 doi:10.1016/j.bmcl.2013.06.030
  1. ↑ Alvarez SE, Harikumar KB, Hait NC, Allegood J, Strub GM, Kim EY, Maceyka M, Jiang H, Luo C, Kordula T, Milstien S, Spiegel S. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature. 2010 Jun 24;465(7301):1084-8. doi: 10.1038/nature09128. PMID:20577214 doi:10.1038/nature09128

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/4l02"
Personal tools